NCT07187856: Phase 2 Randomized Study of PG-102 vs Placebo and Semaglutide in Type 2 Diabetes Mellitus
- State
- Not started
- Phase
- Phase 2
- People
- 80 planned
- Started
- Jan 2026
- Primary completion
- Sep 2026
- Arms
- PG-102
- Results
- None posted
- 23 Sep 2025: Trial registered